BrainXell
Madison, US · Delaware corporation
Biotech
Founders & leadership
CS
Chenfeng SongDirector
SD
Shouming DuExecutive Officer, Director
XL
Xinjun LiangDirector
EB
Ed BaetgeDirector
SZ
Su-Chun ZhangDirector
Reported raises · per SEC filings
Form D private placements▶$13.2MraisedSep 2021 · 10 investors · BiotechnologyRule 506(b)
▶$13.2MraisedSep 2021 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chenfeng SongDirector
- Shouming DuExecutive Officer, Director
- Xinjun LiangDirector
- Ed BaetgeDirector
- Su-Chun ZhangDirector
- Offering amount
- $13.2M
- Amount sold
- $13.2M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 8 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $275.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $255.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $221.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $220.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $202.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.